AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
PRIMARY THYROID LYMPHOMA - A RETROSPECTIVE ANALYSIS OF 15 UNSELECTED PATIENTS
Authors: KUPERHOMMEL MJJ VRINTS LW COEBERGH JWW VREUGDENHIL G
Citation: Mjj. Kuperhommel et al., PRIMARY THYROID LYMPHOMA - A RETROSPECTIVE ANALYSIS OF 15 UNSELECTED PATIENTS, Annals of oncology, 9, 1998, pp. 546-546
REGULATION OF IRON-METABOLISM IN THE ACUTE-PHASE RESPONSE - INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA INDUCE HYPOFERREMIA, FERRITIN PRODUCTION AND A DECREASE IN CIRCULATING TRANSFERRIN RECEPTORS IN CANCER-PATIENTS
Authors: FEELDERS RA VREUGDENHIL G EGGERMONT AMM KUIPERKRAMER PA VANEIJK HG SWAAK AJG
Citation: Ra. Feelders et al., REGULATION OF IRON-METABOLISM IN THE ACUTE-PHASE RESPONSE - INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA INDUCE HYPOFERREMIA, FERRITIN PRODUCTION AND A DECREASE IN CIRCULATING TRANSFERRIN RECEPTORS IN CANCER-PATIENTS, European journal of clinical investigation, 28(7), 1998, pp. 520-527
PRIMARY TESTICULAR LYMPHOMA - A RETROSPECTIVE ANALYSIS OF 13 UNSELECTED PATIENTS
Authors: KUPERHOMMEL MJJ VRINTS LW COEBERGH JWW LYBEERT MLM KEUNING JJ VREUGDENHIL G
Citation: Mjj. Kuperhommel et al., PRIMARY TESTICULAR LYMPHOMA - A RETROSPECTIVE ANALYSIS OF 13 UNSELECTED PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 125-125
THE EFFECTS OF APPLYING WAIT-AND-SEE POLICY ON THE WELL-BEING OF PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA OR CHRONIC LYMPHOCYTIC-LEUKEMIA - A PILOT-STUDY
Authors: KRUIJSSEN E VINGERHOETS A KEUNING JJ VREUGDENHIL G
Citation: E. Kruijssen et al., THE EFFECTS OF APPLYING WAIT-AND-SEE POLICY ON THE WELL-BEING OF PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA OR CHRONIC LYMPHOCYTIC-LEUKEMIA - A PILOT-STUDY, British Journal of Haematology, 102(1), 1998, pp. 334-335
HIGH-DOSE DEXAMETHASONE AS A TREATMENT OF IDIOPATHIC THROMBOCYTOPENICPURPURA
Authors: BORST F KEUNING JJ SINNIGE HAM VANHULSTEIJN LH VREUGDENHIL G
Citation: F. Borst et al., HIGH-DOSE DEXAMETHASONE AS A TREATMENT OF IDIOPATHIC THROMBOCYTOPENICPURPURA, British Journal of Haematology, 102(1), 1998, pp. 364-364
FACTORS DETERMINING THE APPRECIATION OF TREATMENT BY ADVANCED COLORECTAL-CANCER PATIENTS
Authors: BREIMERLINCKENS EM VREUGDENHIL G KEUNING JJ VANHALTEREN HK VINGERHOETS AJJM
Citation: Em. Breimerlinckens et al., FACTORS DETERMINING THE APPRECIATION OF TREATMENT BY ADVANCED COLORECTAL-CANCER PATIENTS, European journal of cancer, 33, 1997, pp. 263-263
5-FLUOROURACIL-BASED TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA OUTSIDE CLINICAL-TRIALS - IMPORTANCE OF LIMITED TOXICITY
Authors: VANHALTEREN HK KEUNING JJ VREUGDENHIL G
Citation: Hk. Vanhalteren et al., 5-FLUOROURACIL-BASED TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA OUTSIDE CLINICAL-TRIALS - IMPORTANCE OF LIMITED TOXICITY, Annals of oncology, 8(2), 1997, pp. 203-203
ELEVATED LEVELS OF INFLAMMATORY CYTOKINES IN BONE-MARROW OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE
Authors: JONGENLAVRENCIC M PEETERS HRM WOGNUM A VREUGDENHIL G BREEDVELD FC SWAAK AJG
Citation: M. Jongenlavrencic et al., ELEVATED LEVELS OF INFLAMMATORY CYTOKINES IN BONE-MARROW OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE, Journal of rheumatology, 24(8), 1997, pp. 1504-1509
ADVANCED COLORECTAL-CANCER, REFRACTORY TO INFUSIONAL FLUOROURACIL TREATMENT - EFFICACY OF 2ND LINE FLUOROURACIL IN COMBINATION WITH A DIFFERENT BIOCHEMICAL MODULATION
Authors: VANHALTEREN HK WAGENER DJT VREUGDENHIL G PUNT CJA
Citation: Hk. Vanhalteren et al., ADVANCED COLORECTAL-CANCER, REFRACTORY TO INFUSIONAL FLUOROURACIL TREATMENT - EFFICACY OF 2ND LINE FLUOROURACIL IN COMBINATION WITH A DIFFERENT BIOCHEMICAL MODULATION, Anticancer research, 17(4A), 1997, pp. 2715-2719
SPONTANEOUS REGRESSION OF HEPATOCELLULAR-CARCINOMA
Authors: VANHALTEREN HK SALEMANS JMJI PETERS H VREUGDENHIL G DRIESSEN WMM
Citation: Hk. Vanhalteren et al., SPONTANEOUS REGRESSION OF HEPATOCELLULAR-CARCINOMA, Journal of hepatology, 27(1), 1997, pp. 211-215
CHEMOIMMUNOTHERAPY WITH BLEOMYCIN, VINCRISTINE, LOMUSTINE, DACARBAZINE (BOLD) PLUS INTERFERON-ALPHA FOR METASTATIC MELANOMA - A MULTICENTERPHASE-II STUDY
Authors: PUNT CJA VANHERPEN CML JANSEN RLH VREUGDENHIL G MULLER EW DEMULDER PHM
Citation: Cja. Punt et al., CHEMOIMMUNOTHERAPY WITH BLEOMYCIN, VINCRISTINE, LOMUSTINE, DACARBAZINE (BOLD) PLUS INTERFERON-ALPHA FOR METASTATIC MELANOMA - A MULTICENTERPHASE-II STUDY, British Journal of Cancer, 76(2), 1997, pp. 266-269
PULSED HIGH-DOSE DEXAMETHASONE AS A FIRST AND 2ND LINE TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
Authors: BORST PF VERHEUL W KEUNING JJ DEWITTE TJM VREUGDENHIL G
Citation: Pf. Borst et al., PULSED HIGH-DOSE DEXAMETHASONE AS A FIRST AND 2ND LINE TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA, Blood, 90(10), 1997, pp. 3073-3073
DIAGNOSTIC AND THERAPEUTIC STRATEGIES AND SURVIVAL IN PRIMARY BREAST LYMPHOMA IN THE SOUTH OF THE NETHERLANDS - A POPULATION-BASED RETROSPECTIVE ANALYSIS
Authors: KUPERHOMMEL MJJ VRINTS LW COEBERGH JWW LYBEERT MLM KEUNING JJ VREUGDENHIL G DEWITTE T
Citation: Mjj. Kuperhommel et al., DIAGNOSTIC AND THERAPEUTIC STRATEGIES AND SURVIVAL IN PRIMARY BREAST LYMPHOMA IN THE SOUTH OF THE NETHERLANDS - A POPULATION-BASED RETROSPECTIVE ANALYSIS, Blood, 90(10), 1997, pp. 3918-3918
LONG-TERM TREATMENT OF TRANSFUSIONAL IRON OVERLOAD WITH THE ORAL IRONCHELATOR DEFERIPRONE (L1) - A DUTCH MULTICENTER TRIAL
Authors: KERSTEN MJ LANGE R SMEETS MEP VREUGDENHIL G ROOZENDAAL KJ LAMEIJER W GOUDSMIT R
Citation: Mj. Kersten et al., LONG-TERM TREATMENT OF TRANSFUSIONAL IRON OVERLOAD WITH THE ORAL IRONCHELATOR DEFERIPRONE (L1) - A DUTCH MULTICENTER TRIAL, Annals of hematology, 73(5), 1996, pp. 247-252
IMPROVEMENT OF ERYTHROPOIESIS DURING TREATMENT WITH DEFERIPRONE IN A PATIENT WITH MYELOFIBROSIS AND TRANSFUSIONAL HEMOSIDEROSIS
Authors: SMEETS MEP VREUGDENHIL G HOLDRINET RSG
Citation: Mep. Smeets et al., IMPROVEMENT OF ERYTHROPOIESIS DURING TREATMENT WITH DEFERIPRONE IN A PATIENT WITH MYELOFIBROSIS AND TRANSFUSIONAL HEMOSIDEROSIS, American journal of hematology, 51(3), 1996, pp. 243-244
STENOSIS AND RENOGRAPHIC CHARACTERISTICS IN RENOVASCULAR DISEASE
Authors: SCHREIJ G RITSEMA GH VREUGDENHIL G DELEEUW PW
Citation: G. Schreij et al., STENOSIS AND RENOGRAPHIC CHARACTERISTICS IN RENOVASCULAR DISEASE, The Journal of nuclear medicine, 37(4), 1996, pp. 594-597
IL-6-INDUCED ANEMIA IN RATS - POSSIBLE PATHOGENETIC IMPLICATIONS FOR ANEMIA OBSERVED IN CHRONIC INFLAMMATIONS
Authors: JONGENLAVRENCIC M PEETERS HRM ROZEMULLER H ROMBOUTS WJC MARTENS ACM VREUGDENHIL G PILLAY M COX PH BIJSER M BRUTEL G BREEDVELD FC SWAAK AJG
Citation: M. Jongenlavrencic et al., IL-6-INDUCED ANEMIA IN RATS - POSSIBLE PATHOGENETIC IMPLICATIONS FOR ANEMIA OBSERVED IN CHRONIC INFLAMMATIONS, Clinical and experimental immunology, 103(2), 1996, pp. 328-334
ELEVATED LEVELS OF INFLAMMATORY CYTOKINES IN BONE-MARROW OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE
Authors: JONGENLAVRENCIC M PEETERS HRM WOGNUM A VREUGDENHIL G BREEDVELD FC SWAAK AJG
Citation: M. Jongenlavrencic et al., ELEVATED LEVELS OF INFLAMMATORY CYTOKINES IN BONE-MARROW OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE, Arthritis and rheumatism, 39(9), 1996, pp. 1018-1018
RECOMBINANT-HUMAN-ERYTHROPOIETIN IMPROVES HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE - UTILITY MEASURES CORRELATE STRONGLY WITH DISEASE-ACTIVITY MEASURES
Authors: RALPH H PEETERS M JONGENLAYVRENCIC M BAKKER CH VREUGDENHIL G BREEDVELD FC SWAAK AJG
Citation: H. Ralph et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN IMPROVES HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE - UTILITY MEASURES CORRELATE STRONGLY WITH DISEASE-ACTIVITY MEASURES, Arthritis and rheumatism, 39(9), 1996, pp. 1308-1308
COURSE AND CHARACTERISTICS OF ANEMIA IN PATIENTS WITH RHEUMATOID-ARTHRITIS OF RECENT-ONSET
Authors: PEETERS HRM JONGENLAVRENCIC M RAJA AN RAMDIN HS VREUGDENHIL G BREEDVELD FC SWAAK AJG
Citation: Hrm. Peeters et al., COURSE AND CHARACTERISTICS OF ANEMIA IN PATIENTS WITH RHEUMATOID-ARTHRITIS OF RECENT-ONSET, Annals of the Rheumatic Diseases, 55(3), 1996, pp. 162-168
EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON ANEMIA AND DISEASE-ACTIVITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE - A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND 52 WEEKS CLINICAL-TRIAL
Authors: PEETERS HRM JONGENLAVRENCIC M VREUGDENHIL G SWAAK AJG
Citation: Hrm. Peeters et al., EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON ANEMIA AND DISEASE-ACTIVITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE - A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND 52 WEEKS CLINICAL-TRIAL, Annals of the Rheumatic Diseases, 55(10), 1996, pp. 739-744
SOFT-TISSUE SARCOMA AND HYPERCALCEMIA
Authors: VREUGDENHIL G DEMULDER PHM VANHOESEL Q
Citation: G. Vreugdenhil et al., SOFT-TISSUE SARCOMA AND HYPERCALCEMIA, Annals of oncology, 6(1), 1995, pp. 89-90
INTERACTION OF INFLAMMATORY CYTOKINES AND ERYTHROPOEITIN IN IRON-METABOLISM AND ERYRHROPOIESIS IN ANEMIA OF CHRONIC DISEASE
Authors: JONGENLAVRENCIC M PEETERS HRM VREUGDENHIL G SWAAK AJG
Citation: M. Jongenlavrencic et al., INTERACTION OF INFLAMMATORY CYTOKINES AND ERYTHROPOEITIN IN IRON-METABOLISM AND ERYRHROPOIESIS IN ANEMIA OF CHRONIC DISEASE, Clinical rheumatology, 14(5), 1995, pp. 519-525
ERYTHROPOIETIN PRODUCTION IN HYPERTENSIVE PATIENTS WITH AND WITHOUT RENAL-ARTERY STENOSIS
Authors: VREUGDENHIL G SCHREY G VANES PN TENG HT DELEEUW PW
Citation: G. Vreugdenhil et al., ERYTHROPOIETIN PRODUCTION IN HYPERTENSIVE PATIENTS WITH AND WITHOUT RENAL-ARTERY STENOSIS, Nephron, 70(1), 1995, pp. 137-138
PROLONGED (100 DAY) TREATMENT WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING-FACTOR AFTER ALLOGENEIC BMT - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
Authors: VREUGDENHIL G SCHATTENBERG A MUUS P DEWITTE T
Citation: G. Vreugdenhil et al., PROLONGED (100 DAY) TREATMENT WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING-FACTOR AFTER ALLOGENEIC BMT - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL, Blood, 86(10), 1995, pp. 3877-3877
Risultati: 1-25 | 26-45